Table 1.
Number, % and PCV13 Coverage of the Identified NP Serotypes
| Serotypes | Number Typable 186 |
ST % per Typable SP | Serotypes | Number Typable 186 |
ST % per Typable SP |
|---|---|---|---|---|---|
| 1 | 33 | 17.7 | 15B/15C | 4 | 2.2 |
| 3 | 3 | 1.6 | 17F | 4 | 2.2 |
| 4 | 4 | 2.2 | 18ABC | 12 | 6.5 |
| 5 | 18 | 9.7 | 19A | 8 | 4.3 |
| 6ABC | 24 | 12.9 | 19F | 20 | 10.8 |
| 7A/7F | 3 | 1.6 | 21 | 1 | 0.5 |
| 7C/7B/40 | 1 | 0.5 | 22A/22F | 2 | 1.1 |
| 8 | 2 | 1.1 | 23A | 2 | 1.1 |
| 9V/9F | 5 | 2.7 | 23F | 4 | 2.2 |
| 9N/9L | 2 | 1.1 | 25F | 1 | 0.5 |
| 10A | 2 | 1.1 | 33A/35F/37 | 1 | 0.5 |
| 11A/11D | 3 | 1.6 | 34 | 8 | 4.3 |
| 12F/12A | 5 | 2.7 | 35B | 1 | 0.5 |
| 13 | 2 | 1.1 | 38 | 1 | 0.5 |
| 14 | 10 | 5.4 | |||
| Typable number | 186 | 55.7% | |||
| Number covered by PCV-13 | 144 | 77.4% | |||
| non-typable per total samples | 31 | 9.3% | |||
| Number positive for SP | 217 | 65.0% | |||
| Number negative for SP | 117 | 35.0% | |||
| Total NP samples collected | 334 | 100% | |||
Notes: Serotypes in boldface are those covered by 13-valent pneumococcal conjugate vaccine-13 (PCV-13).